HUTCHMED (China) Balance Sheet Health
Financial Health criteria checks 5/6
HUTCHMED (China) has a total shareholder equity of $743.4M and total debt of $79.3M, which brings its debt-to-equity ratio to 10.7%. Its total assets and total liabilities are $1.3B and $536.4M respectively. HUTCHMED (China)'s EBIT is $18.4M making its interest coverage ratio -0.5. It has cash and short-term investments of $889.0M.
Key information
10.7%
Debt to equity ratio
US$79.34m
Debt
| Interest coverage ratio | -0.5x |
| Cash | US$889.02m |
| Equity | US$743.39m |
| Total liabilities | US$536.39m |
| Total assets | US$1.28b |
Recent financial health updates
No updates
Recent updates
Hutchmed Is Turning Profitable
Mar 20Hutchmed begins dosing in phase 2/3 trial of sovleplenib for red blood cell disorder
Oct 10Hutchmed, Inmagene begin dosing in phase 1 trial of potential autoimmune disease drug IMG-004
Aug 09Hutchmed begins dosing in mid-stage study of tazemetostat in blood cancer subtype
Aug 01Hutchmed begins dosing in early-stage study of cancer drug HMPL-A83
Jul 15Hutchmed, Inmagene begin dosing in early-stage study of IMG-007 for eczema
Jul 06Hutchmed Roils Markets With Changing Of Its Guard, U.S. Delisting Threat
Mar 11HUTCHMED wins regulatory approval in China for cancer therapy
Jun 18Financial Position Analysis
Short Term Liabilities: HCM's short term assets ($1.1B) exceed its short term liabilities ($403.0M).
Long Term Liabilities: HCM's short term assets ($1.1B) exceed its long term liabilities ($133.4M).
Debt to Equity History and Analysis
Debt Level: HCM has more cash than its total debt.
Reducing Debt: HCM's debt to equity ratio has increased from 6.7% to 10.7% over the past 5 years.
Debt Coverage: HCM's debt is well covered by operating cash flow (276.3%).
Interest Coverage: HCM earns more interest than it pays, so coverage of interest payments is not a concern.